Review Article
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
Table 1
Metabolic adaptations in various cell types of different kidney diseases.
| Disease | Cell type | Metabolic adaptations | References |
| ADPKD | Epithelial cells | Glycolysis | [3] | PPP | [4] | Glutamine uptake | [5, 6] | FAO | [7ā9] |
| AKI | TEC | Glycolysis | [11] | OXPHOS | [13, 14, 17] | FAO | [18] |
| CKD | Fibroblasts | Glycolysis | [22] | Glutamine metabolism | [24] | TEC | FAO | [26, 27] | OXPHOS | [28] |
| DKD | Podocytes | Glycolysis | [37] | TEC | Glycolysis | [38] |
| NS, AAV | Monocytes/macrophages | PPP | [41] |
| SLE | Lymphocytes | PPP | [44] |
|
|
FAO, fatty acid oxidation; TEC, tubular epithelial cells; OXPHOS, oxidative phosphorylation; PPP, pentose phosphate pathway; NS, nephrotic syndrome; AAV, ANCA-associated vasculitis.
|